Valuation: Orion Oyj

Market Cap 12.59B 14.1B 11.61B 10.55B 19.79B 1,336B 20.09B 140B 55.1B 700B 52.92B 51.79B 2,217B P/E 2026 *
22.2x
P/E 2027 * 18.9x
Enterprise Value 12.49B 13.99B 11.52B 10.47B 19.64B 1,326B 19.94B 139B 54.68B 694B 52.53B 51.4B 2,200B EV / Sales 2026 *
5.93x
EV / Sales 2027 * 5.15x
Free-Float
90.5%
Yield 2026 *
2.19%
Yield 2027 * 2.42%
1 day+3.09%
1 week+6.52%
Current month+10.64%
1 month+9.45%
3 months+18.52%
6 months+25.34%
Current year+44.55%
1 week 85.4
Extreme 85.4
91.6
1 month 75
Extreme 75
91.6
Current year 62.3
Extreme 62.3
91.6
1 year 56.3
Extreme 56.3
91.6
3 years 32.5
Extreme 32.5
91.6
5 years 32.5
Extreme 32.5
91.6
10 years 24.75
Extreme 24.75
91.6
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.81%+6.52% - - 14.12B
+2.84%+4.79%+61.44%+127.46% 1,133B
+4.21%+6.39%+39.66%+77.99% 621B
-0.09%+0.54%+24.60%+96.87% 503B
+0.03%+3.27%+39.79%+65.06% 379B
-1.22%+2.28%+69.50%+43.68% 370B
+1.58%+2.37%+22.91%+52.52% 292B
+2.90%+2.22%+3.51%+28.51% 262B
+2.25%+3.48%+51.74%+64.48% 237B
+2.09%-0.25%+29.24%+102.39% 190B
Average +1.71%+3.22%+38.04%+73.22% 443.11B
Weighted average by Cap. +1.82%+3.73%+43.34%+85.26%

Financials

2026 *2027 *
Net sales 2.1B 2.36B 1.94B 1.76B 3.31B 223B 3.36B 23.39B 9.22B 117B 8.85B 8.66B 371B 2.38B 2.66B 2.19B 1.99B 3.74B 252B 3.8B 26.43B 10.41B 132B 10B 9.78B 419B
Net income 571M 639M 526M 478M 897M 60.56B 911M 6.34B 2.5B 31.73B 2.4B 2.35B 101B 669M 749M 617M 560M 1.05B 70.95B 1.07B 7.43B 2.93B 37.17B 2.81B 2.75B 118B
Net Debt -94.56M -106M -87.24M -79.26M -149M -10.03B -151M -1.05B -414M -5.26B -398M -389M -16.66B -345M -387M -319M -289M -543M -36.65B -551M -3.84B -1.51B -19.2B -1.45B -1.42B -60.82B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,000
Date Price Change Volume
23/10/26 €91.50 +2.81% 18,608
21/10/26 €89.00 +0.79% 8,811
20/10/26 €88.30 +0.80% 4,240
19/10/26 €87.60 +0.69% 7,138
16/10/26 €87.00 +1.28% 10,030
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
89.85EUR
Average target price
77.33EUR
Spread / Average Target
-13.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Orion Oyj